^"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^Wang J, Su SF, Dresser MJ, Schaner ME, Washington CB, Giacomini KM (Feb 1998). "Na(+)-dependent purine nucleoside transporter from human kidney: cloning and functional characterization". Am J Physiol. 273 (6 Pt 2): F1058-65. doi:10.1152/ajprenal.1997.273.6.F1058. PMID9435697.
Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene. 138 (1–2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID8125298.
Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al. (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". Gene. 200 (1–2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMID9373149.
Pennycooke M, Chaudary N, Shuralyova I, et al. (2001). "Differential expression of human nucleoside transporters in normal and tumor tissue". Biochem. Biophys. Res. Commun. 280 (3): 951–9. doi:10.1006/bbrc.2000.4205. PMID11162617.
Li JY, Boado RJ, Pardridge WM (2001). "Differential kinetics of transport of 2',3'-dideoxyinosine and adenosine via concentrative Na+ nucleoside transporter CNT2 cloned from rat blood–brain barrier". J. Pharmacol. Exp. Ther. 299 (2): 735–40. PMID11602688.
Gerstin KM, Dresser MJ, Giacomini KM (2002). "Specificity of human and rat orthologs of the concentrative nucleoside transporter, SPNT". Am. J. Physiol. Renal Physiol. 283 (2): F344–9. doi:10.1152/ajprenal.00274.2001. PMID12110519. S2CID21332585.
Shin HC, Landowski CP, Sun D, et al. (2003). "Functional expression and characterization of a sodium-dependent nucleoside transporter hCNT2 cloned from human duodenum". Biochem. Biophys. Res. Commun. 307 (3): 696–703. doi:10.1016/S0006-291X(03)01259-2. PMID12893280.
Lang TT, Young JD, Cass CE (2004). "Interactions of nucleoside analogs, caffeine, and nicotine with human concentrative nucleoside transporters 1 and 2 stably produced in a transport-defective human cell line". Mol. Pharmacol. 65 (4): 925–33. doi:10.1124/mol.65.4.925. PMID15044622. S2CID5665725.
Damaraju VL, Visser F, Zhang J, et al. (2005). "Role of human nucleoside transporters in the cellular uptake of two inhibitors of IMP dehydrogenase, tiazofurin and benzamide riboside". Mol. Pharmacol. 67 (1): 273–9. doi:10.1124/mol.104.004408. PMID15486050. S2CID3017992.
Owen RP, Gray JH, Taylor TR, et al. (2005). "Genetic analysis and functional characterization of polymorphisms in the human concentrative nucleoside transporter, CNT2". Pharmacogenet. Genomics. 15 (2): 83–90. doi:10.1097/01213011-200502000-00004. PMID15861032. S2CID12817964.
Fernández-Veledo S, Jover R, Casado FJ, et al. (2007). "Transcription factors involved in the expression of SLC28 genes in human liver parenchymal cells". Biochem. Biophys. Res. Commun. 353 (2): 381–8. doi:10.1016/j.bbrc.2006.12.021. PMID17187757.
Smith KM, Slugoski MD, Cass CE, et al. (2007). "Cation coupling properties of human concentrative nucleoside transporters hCNT1, hCNT2 and hCNT3". Mol. Membr. Biol. 24 (1): 53–64. doi:10.1080/09687860600942534. PMID17453413. S2CID20779608.
Hirsh AJ, Stonebraker JR, van Heusden CA, et al. (2007). "Adenosine deaminase 1 and concentrative nucleoside transporters 2 and 3 regulate adenosine on the apical surface of human airway epithelia: implications for inflammatory lung diseases". Biochemistry. 46 (36): 10373–83. doi:10.1021/bi7009647. PMID17696452.
Li L, Tan CM, Koo SH, et al. (2007). "Identification and functional analysis of variants in the human concentrative nucleoside transporter 2, hCNT2 (SLC28A2) in Chinese, Malays and Indians". Pharmacogenet. Genomics. 17 (9): 783–6. doi:10.1097/FPC.0b013e3281c10e41. PMID17700367.